biotech insider buys Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech insider buys

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	1/18/2008 5:15:09 PM
	Read Replies (2) of 213

John, I have already made the case you asked for at the BMO meeting which was webcast. When we get the new clinical studies started in Europe and complete our market research, I will update shareholders with some additional information. Obviously, many of us at Cortex are confident that we are on the right path and have bought additional shares in our company. No one likes the current stock price, but it is an exceptional buying opportunity for those who believe in our technology and I will continue to buy more over the next month myself. I want to wait until I have a substantial amount of the market research completed before I say a lot more about the opportunity for Cortex. As I have stated before, we have an exceptional technology which I believe we are now developing better than ever before. The next twelve months should allow us to both move clinical trials forward as well as develop our technology platform by pushing new High Impact and Low Impact compounds into the clinic. Having a broadened base of operation should help us attract new interest from a licensing point of view and from investors. Roger [Roger in this case is Roger Stoll - the CEO and chairman of Cortex (COR)]. siliconinvestor.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next